ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has been named one of the 50 most successful and innovative technology companies of the Pittsburgh region by the Pittsburgh Technology Council.
Shortlisted for the Health IT Innovator of the Year Award, ERT has been recognized for its suite of innovative clinical trial solutions that pharmaceutical researchers rely on to determine the safety and effectiveness of new medical treatments. ERT’s electronic Clinical Outcome Assessment (eCOA), Cardiac Safety, Respiratory, Imaging, Real World Evidence and Trial Oversight solutions improve clinical trial efficiencies, overcome the limitations of traditional paper-and-pencil approaches, and deliver the highest quality patient data so that sponsors can accelerate clinical development and get treatments to the patients who need them sooner.
“We’re honored to receive the Tech 50 recognition and to be considered a leading health technology company not only in Pittsburgh, but around the globe,” said Jim Corrigan, President, and CEO, ERT. “It’s a great source of pride for our employees knowing the solutions we deliver play a key role in the clinical research that leads to treatment and cures for diseases affecting millions of patients worldwide.”